Trimeris Expands Fuzeon Distribution; Reimbursement Remains Challenge
Executive Summary
Roche and Trimeris are expanding distribution of the HIV therapy Fuzeon into retail channels through StatScript, the companies said during an analyst call Sept. 25
You may also be interested in...
Gilead Leads Biotech Rebound In 2003: Product Stories Play Well
Gilead Sciences is leading a new wave of biotech stocks attempting to break out of the start-up phase to become full-fledged biopharma companies
Gilead Leads Biotech Rebound In 2003: Product Stories Play Well
Gilead Sciences is leading a new wave of biotech stocks attempting to break out of the start-up phase to become full-fledged biopharma companies
Rx Access PR Effort Needs Hiatus, Pfizer Says; Roche Wants To Get Personal
Industry should take a hiatus from public relations messages that advocate patient access to drugs, Pfizer VP-Corporate Affairs Robert Mallett said at the Pharmaceutical Leadership Forum Conference in Washington, D.C. Nov. 18